Evidence map›Paper›PMID 30513601›Full record

ReviewMarine drugs2018

Chemically-Induced Production of Anti-Inflammatory Molecules in Microalgae.

Zaida Montero-Lobato, María Vázquez, Francisco Navarro, Juan Luis Fuentes, Elisabeth Bermejo, Inés Garbayo, Carlos Vílchez, María Cuaresma

Open access · goldAbstract readReview
In one paragraph

Review in Marine drugs, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 59 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Antimicrobial Activity ofInternational journal of molecular sciences · 2024
    Review
  6. Article
  7. Review
  8. Protective Effects ofLife (Basel, Switzerland) · 2023
    Article
  9. Article
  10. Review
  11. Acta pharmaceutica Sinica. B · 2023
    Article
  12. Assessment of the Effects of Edible Microalgae in a Canine Gut Model.Animals : an open access journal from MDPI · 2022
    Article
  13. Article
  14. Marine drugs · 2021
    Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Zaida Montero-LobatoAlgal Biotechnology Group, CIDERTA, RENSMA and Faculty of Sciences, University of Huelva, 21007 Huelva, Spain. mariazaida.montero@alu.uhu.es.
María VázquezAlgal Biotechnology Group, CIDERTA, RENSMA and Faculty of Sciences, University of Huelva, 21007 Huelva, Spain. maria.vazquez@ciecema.uhu.es.
Francisco NavarroDepartment of Integrated Sciences, Cell Biology, Faculty of Experimental Sciences, University of Huelva, 21007 Huelva, Spain. fnavarro@dbasp.uhu.es.ORCID 0000-0002-6384-5575
Juan Luis FuentesAlgal Biotechnology Group, CIDERTA, RENSMA and Faculty of Sciences, University of Huelva, 21007 Huelva, Spain. jlfuentes@dqcm.uhu.es.
Elisabeth BermejoAlgal Biotechnology Group, CIDERTA, RENSMA and Faculty of Sciences, University of Huelva, 21007 Huelva, Spain. elisabeth.bermejo@dqcm.uhu.es.
Inés GarbayoAlgal Biotechnology Group, CIDERTA, RENSMA and Faculty of Sciences, University of Huelva, 21007 Huelva, Spain. garbayo@uhu.es.
Carlos VílchezAlgal Biotechnology Group, CIDERTA, RENSMA and Faculty of Sciences, University of Huelva, 21007 Huelva, Spain. cvilchez@uhu.es.ORCID 0000-0002-8164-1672
María CuaresmaAlgal Biotechnology Group, CIDERTA, RENSMA and Faculty of Sciences, University of Huelva, 21007 Huelva, Spain. maria.cuaresma@dqcm.uhu.es.ORCID 0000-0003-2183-9342
Universidad de Huelva · ES

Funding

Universidad de Huelva Fellowship holder
6 · The paper itself

Abstract

Microalgae have been widely recognized as a valuable source of natural, bioactive molecules that can benefit human health. Some molecules of commercial value synthesized by the microalgal metabolism have been proven to display anti-inflammatory activity, including the carotenoids lutein and astaxanthin, the fatty acids EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid), and sulphated polysaccharides. These molecules can accumulate to a certain extent in a diversity of microalgae species. A production process could become commercially feasible if the productivity is high and the overall production process costs are minimized. The productivity of anti-inflammatory molecules depends on each algal species and the cultivation conditions, the latter being mostly related to nutrient starvation and/or extremes of temperature and/or light intensity. Furthermore, novel bioprocess tools have been reported which might improve the biosynthesis yields and productivity of those target molecules and reduce production costs simultaneously. Such novel tools include the use of chemical triggers or enhancers to improve algal growth and/or accumulation of bioactive molecules, the algal growth in foam and the surfactant-mediated extraction of valuable compounds. Taken together, the recent findings suggest that the combined use of novel bioprocess strategies could improve the technical efficiency and commercial feasibility of valuable microalgal bioproducts production, particularly anti-inflammatory compounds, in large scale processes.

Indexed as

PhotobioreactorsAnti-Inflammatory AgentsBiological FactorsHumansLightMicroalgaeOxidative StressSurface-Active AgentsTemperatureAnti-Inflammatory AgentsBiological FactorsSurface-Active Agentsanti-inflammatorybioactive moleculescarotenoidsmicroalgaepolysaccharidespolyunsaturated fatty acids

Identifiers

PMID30513601
PMCPMC6315467
OpenAlexW2902658362

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.